Stefania Orlando

11PUBLICATIONS
8CO-AUTHORS
Rheumatology and arthritisRegenerative medicine (incl. stem cells)Medical infection agents (incl. prions)Toxicology (incl. clinical toxicology)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jun 26, 2026
Ocrelizumab-Induced Brain Volume Dynamics in Relapsing-Remitting Multiple Sclerosis.

|Nov 27, 2025
The Age-Related Efficacy of Dimethyl Fumarate in Naive Versus Switcher Multiple Sclerosis Patients: A Multicenter Population-Based Study.

Roberto De Masi, Stefania Orlando, Assunta Greco

|Jul 13, 2024
Ultrastructural Characterization of PBMCs and Extracellular Vesicles in Multiple Sclerosis: A Pilot Study.

Roberto De Masi, Stefania Orlando, Elisabetta Carata

|Sep 09, 2023
Multi-Criterial Model for Weighting Biological Risk Factors in Multiple Sclerosis: Clinical and Health Insurance Implications.

Roberto De Masi, Stefania Orlando, Chiara Leo

|Feb 11, 2023
Fluphenazine-Induced Neurotoxicity with Acute Almost Transient Parkinsonism and Permanent Memory Loss: Lessons from a Case Report.

Roberto De Masi, Stefania Orlando, Vincenzo Toni

|Nov 11, 2022
Changes in Brain Volumes Are Relevant during Natalizumab-Associated Progressive Multifocal Leukoencephalopathy: Lessons from a Case Report.

Roberto De Masi, Stefania Orlando, Silvia Armenise

Pageof 2

Frequent Collaborators

10 joint publications

Roberto De Masi

1 joint publications

Antonella De Donno

1 joint publications

Francesco Bagordo

1 joint publications

Tiziana Grassi